WebFeb 28, 2024 · SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & … WebPPD Laboratory Services’ central lab performs cell-based assays and flow cytometry under good clinical laboratory practice (GCLP) and/or clinical laboratory improvement amendment (CLIA) regulations. Our central lab test menu includes both routine cell surface assays as well as intracellular assays. We have capability for four-, six- and eight ...
Homepage - DiaSorin Molecular
WebFeb 13, 2024 · SALUGGIA, Italy and FREMONT, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) … WebFeb 13, 2024 · Cytek ® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin. Sale of assets related to Flow Cytometry & Imaging (FCI) Business Unit; … sims chingyu cas ver basic traits v2.4
Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin
WebFeb 28, 2024 · DiaSorin S.p.A. - Share Capital €55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 Headquarter via … WebSale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed SALUGGIA, Italy, and FREMONT, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the … WebApr 9, 2024 · The performance of a laboratory-developed quantitative IgG/IgA flow cytometry-based immunoassay (FCI) using Jurkat T cells stably expressing full-length native S protein was compared against Elecsys® electrochemiluminiscent (ECLIA) Anti-SARS-CoV-2 S (Roche Diagnostics, Pleasanton, CA, USA), and LIAISON® SARS-CoV … rc or